The New York Times: Health, Work, Lies On Wednesday, Douglas Elmendorf, the director of the nonpartisan Congressional Budget Office, said the obvious: losing your job and choosing to work less aren't the same thing. If you lose your job, ...
Tags: Health, Labor Market, Obamacare, 'Narrow Networks'
The UK’s University of Leeds has fabricated what is claimed to be the world’s most powerful terahertz (THz) laser chip, exceeding 1 Watt output power from a quantum cascade laser (QCL) (Lianhe Li et al, ‘Terahertz quantum ...
Tags: Laser Chip, Electronics
Clinical trials investigating new uses for the anti-cancer drug Avastin have produced mixed results. When combined with standard chemotherapy, Avastin extended the survival of patients with advanced cervical cancer by nearly four months, ...
University of Leeds researchers have taken the lead in the race to build the world's most powerful terahertz laser chip. A paper in the Institution of Engineering and Technology's (IET) journal Electronics Letters reports that the Leeds ...
Incyte Corporation (Nasdaq: INCY) announced today that it has entered into a clinical trial collaboration agreement with Merck, through a Merck subsidiary, to evaluate the safety and efficacy of Incyte's oral indoleamine dioxygenase-1 ...
Tags: collaboration agreement, Incyte's oral indoleamine dioxygenase-1, IDO1
The first comprehensive, large-scale cohort study of the long-term survival of children treated for low-grade gliomas, the most common pediatric brain tumor, finds that almost 90 percent are alive 20 years later and that few die from the ...
Tags: Health&Medicine
A group of prominent healthcare experts including bioethicists, pharmacists, policymakers and cancer specialists have proposed concrete steps for preventing and managing a nightmare scenario that is becoming all too common: shortages of ...
Tags: Healthcare, Life-Saving Drugs
If Nuvilex can use the Cell-in-a-Box technology to develop marijuana-based treatments for cancer with the same success it has seen in two independent clinical trials to develop a treatment for advanced inoperable pancreatic cancer, then the ...
Nuvilex has announced that its subsidiary, Medical Marijuana Sciences, plans to use the proprietary cellulose-based live-cell encapsulation technology known as Cell-in-a-Box to develop treatments for serious and deadly forms of cancer. ...
MONDAY Jan.27,2014,2014--Doctors have a vital role in increasing the number of girls and young women who get a vaccine that helps protect them against cervical cancer,according to a new study. Despite calls by experts for universal human ...
Tags: Hpv Vaccination, HPV, Medicine
A common surgery for non-melanoma skin cancer, known as Mohs surgery typically achieves excellent results but can be a long process, as the surgeon successively removes the area of concern until the surrounding tissue is free of cancer. To ...
Tags: Optical imaging, skin cancer
Their joint aim is to identify new therapeutic targets in ‘triple negative’ breast cancers Curie-Cancer, the body which leads the Institut Curie's industry partner research activity, and Servier, today announce that they have ...
Tags: triple negative, Curie-Cancer, TTK/MPS1, Institut Curie and Servier
For the fourth consecutive year, outcomes for patients receiving allogeneic transplants through the Blood and Marrow Transplant Program at Roswell Park Cancer Institute (RPCI) have been shown to be significantly better than would be ...
Ewing's Sarcoma is an aggressive pediatric cancer, most commonly caused by the improper fusion of the gene EWS with the gene FLI1. Though the cause has long been known, therapeutic targeting of this fusion has to date proven very difficult. ...
Tags: Ewing's Sarcoma, health, gene
Agenus Inc. (Nasdaq: AGEN), a biotechnology company developing novel immune system activating treatments for cancers and infectious diseases, announced that Phase 2 results of Prophage G-200 vaccine in recurrent patients with glioblastoma ...